Accessibility Menu
 
Vitrolife Ab (publ) logo

Vitrolife Ab (publ)

(OTC) VTRLY

Current Price$11.00
Market Cap$1.49B
Since IPO (2016)-5%
5 Year-56%
1 Year-39%
1 Month+7%

Vitrolife Ab (publ) Financials at a Glance

Market Cap

$1.49B

Revenue (TTM)

$3.43B

Net Income (TTM)

$5.01B

EPS (TTM)

$-3.95

P/E Ratio

-2.79

Dividend

$0.11

Beta (Volatility)

0.08 (Low)

Price

$11.00

Volume

40

Open

$11.00

Previous Close

$11.00

Daily Range

$11.00 - $11.00

52-Week Range

$9.50 - $18.55

VTRLY News

No articles available.

VTRLY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vitrolife Ab (publ)

Industry

Biotechnology

Employees

1,151

CEO

Bronwyn Brophy O'Connor

Headquarters

Gothenburg, 421 32, SE

VTRLY Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

18%

Net Income Margin

-1%

Return on Equity

-51%

Return on Capital

6%

Return on Assets

-45%

Earnings Yield

-35.84%

Dividend Yield

0.01%

Payout Ratio

-2.97%

Stock Overview

Market Cap

$1.49B

Shares Outstanding

135.42M

Volume

40

Short Interest

0.00%

Avg. Volume

411.532

Financials (TTM)

Gross Profit

$2.00B

Operating Income

$579.03M

EBITDA

$980.41M

Operating Cash Flow

$596.89M

Capital Expenditure

$253.80M

Free Cash Flow

$343.10M

Cash & ST Invst.

$809.00M

Total Debt

$1.60B

Vitrolife Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$891.00M

-7.1%

Gross Profit

$517.00M

-11.8%

Gross Margin

58.02%

N/A

Market Cap

$1.49B

N/A

Market Cap/Employee

$1.30M

N/A

Employees

1,150

N/A

Net Income

$5.31B

-3921.9%

EBITDA

$5.27B

-2043.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$796.00M

+16.6%

Accounts Receivable

$806.00M

+5.1%

Inventory

$413.00M

-2.1%

Long Term Debt

$1.56B

-19.0%

Short Term Debt

$86.00M

-46.2%

Return on Assets

-45.06%

N/A

Return on Invested Capital

5.86%

N/A

Free Cash Flow

$82.20M

-69.3%

Operating Cash Flow

$154.34M

-42.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OSSUYEmbla Medical hf.
$3.81+0.00%
MEDGFMedacta Group S.A.
$83.91+0.00%
STSEYStratec SE
$5.51+0.00%
HBMHFHBM Holdings Limited
$1.56+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About VTRLY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.